Hypofractionated Proton Beam Therapy of 51.6Gy(RBE) in 12 fractions (3 weeks) with real-time-image gated spot-scanning system for non-metastatic prostate cancer (T1c-T4N0M0) - Hypofractionated Proton Beam Therapy of 51.6Gy(RBE) in 12 fractions (3 weeks) for non-metastatic prostate cancer (T1c-T4N0M0)

Kyoto Prefectural University of Medicine Department of Radiology0 个研究点目标入组 180 人开始时间: 2022年2月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Prior radiotherapy to the pelvic area Prior prostate cancer therapy such as: prostatectomy, radiation therapy, chemotherapy or high intensity focused ultrasound (HIFU) . Patients with previous Transurethral Resection of the Prostate (TURP) performed for urinary retention may be included. Second invasive malignancy (except of carcinoma in situ, treated by optimal therapy) if not controlled within last 5 years. It is clinically difficult to place fiducial markers into prostate. There is uncontrollable inflammation in pelvic lesion or inflammatory systemic disease. It is difficult to provide study-specific informed consent prior to study entry.

发起方

Kyoto Prefectural University of Medicine Department of Radiology